These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Failure of aspirin to prevent incorporation of indium-111 labelled platelets into cardiac thrombi in man.
    Author: Ezekowitz MD, Cox AC, Smith EO, Taylor FB.
    Journal: Lancet; 1981 Aug 29; 2(8244):440-3. PubMed ID: 6115201.
    Abstract:
    The in vitro and in vivo behaviour of platelets was studied in eleven patients with left ventricular aneurysms and mural thrombi. Five patients were on aspirin 300-2400 mg/day; the remaining six patients were controls. In vitro function was tested by the aggregation response of platelets to adenosine diphosphate (ADP) and collagen. In vivo function was assessed by the incorporation of indium-111-labelled platelets into cardiac thrombi as measured by scintigraphy. Platelets from patients on aspirin, whether tested before or after labelling, aggregated less with collagen than did those of controls (18 vs 52%; p less than 0.01 before labelling, 13 vs 49%; p less than 0.02 after labelling). Second wave aggregation, induced by ADP, was impaired in patients on aspirin. In all patients scintigraphy showed that the autologous labelled platelets were incorporated into ventricular thrombi. Thus, although in vitro the platelets from patients on aspirin aggregated subnormally, in vivo they took part in thrombosis.
    [Abstract] [Full Text] [Related] [New Search]